Radicava ors — Blue Cross Blue Shield of Illinois
any other FDA-labeled or compendia-supported indication
Initial criteria
- The member resides in Ohio AND
- The plan is Fully Insured or HIM Shop (SG) AND BOTH of the following:
- A. The patient does NOT have any FDA-labeled contraindications to the requested agent AND
- B. ONE of the following:
- 1. The patient has another FDA-labeled indication for the requested agent and route of administration OR
- 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
- 3. The prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use(s) as generally safe and effective
Approval duration
12 months